These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 19709563

  • 1. [Dermatologic toxicity to sorafenib].
    Velázquez D, de la Cueva P, Zamberk P, Lázaro P.
    Actas Dermosifiliogr; 2009; 100(6):518-20. PubMed ID: 19709563
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
    Yang CH, Lin WC, Chuang CK, Chang YC, Pang ST, Lin YC, Kuo TT, Hsieh JJ, Chang JW.
    Br J Dermatol; 2008 Mar; 158(3):592-6. PubMed ID: 18070211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Perforating folliculitis, angioedema, hand-foot syndrome--multiple cutaneous side effects in a patient treated with sorafenib.
    Wolber C, Udvardi A, Tatzreiter G, Schneeberger A, Volc-Platzer B.
    J Dtsch Dermatol Ges; 2009 May; 7(5):449-52. PubMed ID: 19178612
    [Abstract] [Full Text] [Related]

  • 9. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
    Lipworth AD, Robert C, Zhu AX.
    Oncology; 2009 May; 77(5):257-71. PubMed ID: 19923864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
    Park YJ, Soh BW, Lee ES.
    Eur J Dermatol; 2017 Apr 01; 27(2):209-210. PubMed ID: 28251899
    [No Abstract] [Full Text] [Related]

  • 15. Penile involvement with hand-foot syndrome.
    Sorscher SM.
    Am J Clin Dermatol; 2004 Apr 01; 5(3):209-10. PubMed ID: 15186201
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hand-foot and stump syndrome to sorafenib.
    Lai SE, Kuzel T, Lacouture ME.
    J Clin Oncol; 2007 Jan 20; 25(3):341-3. PubMed ID: 17235051
    [No Abstract] [Full Text] [Related]

  • 18. [Hand-foot syndrome and sorafenib].
    Milano G, Mortier L, Digue L, Desmedt E, Ravaud A.
    Bull Cancer; 2009 Feb 20; 96(2):191-7. PubMed ID: 19258226
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
    Battistella M, Frémont G, Vignon-Pennamen MD, Gornet JM, Dubertret L, Viguier M.
    Arch Dermatol; 2008 Oct 20; 144(10):1400-2. PubMed ID: 18936416
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.